-allegedly the panel chair is a GSK consultant and was the only no on efficacy - I believe some panel members asked for a 10k patient trial - I also read on twitter that The CBER recommended a post approval study
I hate to be the conspiracy theorist, but I thought they got hosed. is it still possible to listen to the panel? If you have time, could you? You will prob need a few toothpicks to keep your eyes open.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.